Arpida purchased TLT Medical Ltd.
Arpida, a biopharmaceutical company listed on the SWX Swiss Exchange, purchased all shares in Swiss biotechnology group TLT Medical Ltd. for an undisclosed consideration.
Lenz & Staehelin advised Arpida. Lenz & Staehelin's team was led by Lukas Morscher and included Philipp Jermann.